CSCIF OTC
COSCIENS Biopharma Inc.
1W: +5.6%
1M: +29.3%
3M: -8.7%
YTD: +4.2%
$6.44
+0.02 (+0.31%)
Weekly Expected Move ±8.4%
$5
$6
$6
$7
$8
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$29M
-16.3% ▼
Total Liabilities
$24M
+10.0% ▲
Shareholders Equity
$5M
-60.0% ▼
Cash & Investments
$10M
-39.0% ▼
Total Debt
$3M
-11.4% ▼
Net Debt
-$7M
+49.8% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2025 |
|---|---|
| — Assets — | |
| Cash | $10M |
| Short-Term Investments | $0 |
| Cash & ST Investments | $10M |
| Net Receivables | $2M |
| Inventory | $2M |
| Other Current Assets | $303K |
| Total Current Assets | $16M |
| Property, Plant & Equip. | $13M |
| Goodwill & Intangibles | $0 |
| Long-Term Investments | $171K |
| Other Non-Current Assets | $0 |
| Total Non-Current Assets | $14M |
| Total Assets | $29M |
| — Liabilities — | |
| Accounts Payable | $1M |
| Short-Term Debt | $294K |
| Deferred Revenue | $0 |
| Other Current Liabilities | $3M |
| Total Current Liabilities | $5M |
| Long-Term Debt | $0 |
| Other Non-Current Liab. | $15M |
| Total Non-Current Liabilities | $19M |
| Total Liabilities | $24M |
| — Equity — | |
| Common Stock | $31M |
| Retained Earnings | -$28M |
| Accumulated OCI | -$3M |
| Total Stockholders Equity | $5M |
| Total Liabilities & Equity | $29M |
| — Key Metrics — | |
| Total Debt | $3M |
| Net Debt | -$7M |
| Total Investments | $171K |